Terumo (OTCMKTS:TRUMY - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.16 EPS for the quarter, Zacks reports. The company had revenue of $1.73 billion during the quarter.
Terumo Stock Performance
OTCMKTS TRUMY traded up $0.15 during mid-day trading on Monday, reaching $18.21. 138,110 shares of the stock were exchanged, compared to its average volume of 247,317. Terumo has a 1 year low of $14.06 and a 1 year high of $21.22. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. The business's 50 day moving average is $19.16 and its 200-day moving average is $19.09. The company has a market capitalization of $26.96 billion, a P/E ratio of 39.39 and a beta of 0.64.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Recommended Stories
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
